# François Cornelis

> François Cornelis is a Series B investor at Innovation Fund backing Health Care and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Innovation Fund](https://shizune.co/investors/profile/innovation-fund-2)
- Total investments: 1
- Last investment: May 2019
- Lead investor: 0%
- Last updated: Aug 2026

François Cornelis is a Series B investor at Innovation Fund focused on Health Care and Biotechnology. François Cornélis is the Founder, Chairman and CEO of Innovation Circle.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cognivia | Tools4Patient (T4P) takes an academic approach to the commercialization of technology centered around the optimization and acceleration of therapeutic drug development programs. The first product launched is Placebell©™, which through a variety of data capture sources and analyses characterizes the individual placebo response in subjects andpatients enrolled in clinical trials.Founded in 2013 and based in Gosselies, Belgium, Tools4Patient is a privately- held innovative company engaged in creating analytical tools with both research and clinical applications. The company strives to improve patient quality of life by supporting physicians’ and pharmaceutical/biotechnology companies’ efforts in identifying the right therapeutic for each individual patient.The company is taking full advantage of its founders’ extensive expertise and experience in drug development. Their experience and that of their extensive professional network of advisors, consultants, and collaborators provide T4P’s core scientists and operational groups with the efficiency, practical know-how, and knowledge required to achieve the company’s objectives. Patients, however, are the essential link in the development of future treatments; T4P could not continue to develop new technologies without them. Therefore, care is taken to ensure that patients are involved at every stage of development, listening constantly to their needs and seeing them as critical stakeholders in the clinical research process. | $4.4M | Series B | May 16, 2019 |  |

1 of 1 investments shown.

## Co-investors
- [Sambrinvest](https://shizune.co/investors/profile/sambr-invest) — VC Fund, 1 deal together

## About Innovation Fund

VC Fund · Brussels, Belgium

Chemical, Advanced Materials, Cosmetics, Recycling, CleanTech, Plastics and Rubber Manufacturing, Nanotechnology, Biosciences

3 contacts available at Innovation Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Pol-Henry Bonte | Partner | https://shizune.co/investors/profile/pol-henry-bonte |
| François Cornelis | Founder, CEO and Chairman | https://shizune.co/investors/profile/fran%C3%A7ois-cornelis |
| Olivier Chapelle | Director | https://shizune.co/investors/profile/olivier-chapelle-0ca4 |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does François Cornelis invest in?

François Cornelis invests primarily in Health Care and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did François Cornelis last invest?

The most recent investment recorded for François Cornelis closed in May 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co